alexa Pharmacology of amezinium, a novel antihypotensive drug. IV. Biochemical investigations of the mechanism of action.
Pharmaceutical Sciences

Pharmaceutical Sciences

Pharmaceutica Analytica Acta

Author(s): Traut M, Brode E, Hoffmann HD

Abstract Share this page

Abstract The possible sites of action of 4-amino-6-methoxy-1-phenyl-pyridazinium methyl sulfate (ameziniummetilsulfate, LU 1631, Regulton), in the following briefly called amezinium, were investigated in biochemical experiments. 1. In vivo in mice, amezinium inhibits the uptake of 3H-noradrenaline into heart and adrenals (among other tissues). The Ki for this inhibition determined in vitro with rat atria is 1.3 x 10(-7) mol/l. As is shown with synaptosomes amezinium exhibits a predilection for the noradrenaline transport, the uptake of dopamine and serotonin being also inhibited, but less so. 2. Amezinium itself is taken up into synaptosomes. This transport follows Michaelis-Menten kinetics, showing the same dependence on Na+ and K+ as uptake 1 of noradrenaline, and is also inhibited by desipramine and cocaine. 3. Storage of 3H-amezinium in rat atria in vivo is almost completely inhibited by pretreatment with 6-hydroxy-dopamine and by approx. 50\% inhibited by pretreatment with reserpine. This indicates that amezinium is at least partly stored in the neuronal granules. 4. Amezinium inhibits MAO-A in rat heart homogenate with a Ki of 3 x 10(-6) mol/l and MAO-B in liver homogenate with a Ki of 3 x 10(-4) mol/l; the inhibition is reversible. 5. Even high doses of amezinium do not deplete catecholamines in the heart or adrenals of the rat. The role of the various sites of action is discussed and the effect of amezinium interpreted as the result of noradrenaline release with simultaneous inhibition of intraneuronal and extraneuronal MAO-A and of uptake 1.
This article was published in Arzneimittelforschung and referenced in Pharmaceutica Analytica Acta

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords